(0.59%) 5 076.50 points
(0.35%) 38 201 points
(0.81%) 17 580 points
(0.68%) $79.54
(2.07%) $1.972
(-0.02%) $2 310.60
(-0.50%) $26.62
(0.62%) $960.80
(0.15%) $0.934
(0.46%) $11.08
(0.07%) $0.799
(-1.56%) $91.80
-0.29% £ 1 700.00
Live Chart Being Loaded With Signals
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally...
Stats | |
---|---|
Volumen de hoy | 786 135 |
Volumen promedio | 8.26M |
Capitalización de mercado | 68.99B |
EPS | £0 ( 2024-01-31 ) |
Próxima fecha de ganancias | ( £0.464 ) 2024-05-08 |
Last Dividend | £14.00 ( 2023-08-17 ) |
Next Dividend | £0 ( N/A ) |
P/E | 14.17 |
ATR14 | £0.943 (0.06%) |
Volumen Correlación
GlaxoSmithKline PLC Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
GlaxoSmithKline PLC Correlación - Moneda/Commodity
GlaxoSmithKline PLC Finanzas
Annual | 2023 |
Ingresos: | £30.33B |
Beneficio Bruto: | £21.25B (70.07 %) |
EPS: | £1.220 |
FY | 2023 |
Ingresos: | £30.33B |
Beneficio Bruto: | £21.25B (70.07 %) |
EPS: | £1.220 |
FY | 2022 |
Ingresos: | £29.32B |
Beneficio Bruto: | £19.77B (67.42 %) |
EPS: | £1.220 |
FY | 2021 |
Ingresos: | £34.11B |
Beneficio Bruto: | £22.51B (65.99 %) |
EPS: | £1.082 |
Financial Reports:
No articles found.
GlaxoSmithKline PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£16.25 (N/A) |
£13.75 (N/A) |
£13.75 (N/A) |
£14.00 (N/A) |
£14.00 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £8.75 | 1993-03-01 |
Last Dividend | £14.00 | 2023-08-17 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 107 | -- |
Total Paid Out | £2 098.00 | -- |
Avg. Dividend % Per Year | 3.06% | -- |
Score | 6.28 | -- |
Div. Sustainability Score | 9.66 | |
Div.Growth Potential Score | 7.40 | |
Div. Directional Score | 8.53 | -- |
Year | Amount | Yield |
---|---|---|
1993 | £0 | 0.00% |
1994 | £0 | 0.00% |
1995 | £0 | 0.00% |
1996 | £0 | 0.00% |
1997 | £0 | 0.00% |
1998 | £0 | 0.00% |
1999 | £0 | 0.00% |
2000 | £0 | 0.00% |
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £100.00 | 6.78% |
2019 | £100.00 | 6.62% |
2020 | £100.00 | 5.59% |
2021 | £100.00 | 7.21% |
2022 | £76.25 | 4.74% |
2023 | £41.75 | 2.90% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TBCG.L | Dividend Knight | 2023-09-07 | Annually | 8 | 3.12% | |
KWS.L | Dividend Knight | 2023-10-05 | Annually | 12 | 0.03% | |
CGS.L | Dividend King | 2023-07-20 | Semi-Annually | 33 | 4.73% | |
RDW.L | Dividend Knight | 2023-09-21 | Annually | 31 | 3.30% | |
GRG.L | Dividend Knight | 2023-09-07 | Semi-Annually | 32 | 1.71% | |
APTD.L | Dividend Knight | 2023-08-03 | Semi-Annually | 32 | 0.82% | |
TSCO.L | Dividend King | 2023-05-11 | Semi-Annually | 32 | 4.53% | |
MFX.L | Dividend Knight | 2023-06-15 | Annually | 4 | 1.28% | |
CSN.L | Dividend Knight | 2023-09-28 | Semi-Annually | 21 | 4.56% | |
SBRE.L | Dividend Knight | 2023-08-17 | Semi-Annually | 7 | 2.15% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.162 | 1.500 | 6.75 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0835 | 1.200 | 7.22 | 8.66 | [0 - 0.3] |
returnOnEquityTTM | 0.387 | 1.500 | 6.82 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.456 | -1.000 | 5.44 | -5.44 | [0 - 1] |
currentRatioTTM | 0.885 | 0.800 | -0.575 | -0.460 | [1 - 3] |
quickRatioTTM | 0.597 | 0.800 | -1.192 | -0.954 | [0.8 - 2.5] |
cashRatioTTM | 0.139 | 1.500 | -0.337 | -0.505 | [0.2 - 2] |
debtRatioTTM | 0.288 | -1.500 | 5.21 | -7.81 | [0 - 0.6] |
interestCoverageTTM | 9.12 | 1.000 | 7.73 | 7.73 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.613 | 2.00 | 9.46 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.035 | 2.00 | 9.48 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.271 | -1.500 | 4.92 | -7.37 | [0 - 2.5] |
grossProfitMarginTTM | 0.720 | 1.000 | 1.330 | 1.330 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.238 | 1.000 | 7.24 | 7.24 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.386 | 1.000 | 8.97 | 8.97 | [0.2 - 2] |
assetTurnoverTTM | 0.514 | 0.800 | 9.91 | 7.93 | [0.5 - 2] |
Total Score | 9.66 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 14.03 | 1.000 | 8.68 | 0 | [1 - 100] |
returnOnEquityTTM | 0.387 | 2.50 | 7.95 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.035 | 2.00 | 9.65 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.22 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.613 | 2.00 | 9.46 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.456 | 1.500 | 5.44 | -5.44 | [0 - 1] |
pegRatioTTM | 22.45 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.216 | 1.000 | 7.11 | 0 | [0.1 - 0.5] |
Total Score | 7.40 |
GlaxoSmithKline PLC
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico